ArticleJournal of oncology2022

Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial.

Weiping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.